Our ambitions are big and our product pipeline has never been stronger. We’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere.To Our Investors Why Invest Financial Reports Events and Presentations Stock Information...
"While we see several assets in Pfizer's pipeline (particularly in oncology) that could make the story more interesting, we believe that further advancement ... will be necessary to change the current narrative on shares which would primarily occur 2026+," JP Morgan analyst Chris Schott wrote ...
Areas of Focus Revolutionary medicines enable us to enrich and extend life for people living with all types of diseases. Rare Disease Internal Medicine Inflammation & Immunology Vaccines Oncology Anti Infectives Pipeline Snapshot as of February 4, 2025 ...
Areas of Focus Revolutionary medicines enable us to enrich and extend life for people living with all types of diseases. Rare Disease Internal Medicine Inflammation & Immunology Vaccines Oncology Anti Infectives Pipeline Snapshot as of February 4, 2025 ...
We're elevating our breakthroughs in a bold new way on Pfizer.com. Check out our new visualized product pipeline, where you'll be able to take a deep dive into our working innovations and see where each product is in development!
A series of multibillion-dollar acquisitions have yet to yield new blockbusters, and Pfizer’s internal pipeline has generated little in the way of excitement. The company’s shares have fallen by more than 50% since their pandemic peak in 2021. In October, activist investor Starboard Value ...
“I’m excited for what’s ahead and confident that we will enhance shareholder value as we sharpen our focus to improve the productivity of our R&D pipeline and advance the clear strategic priorities guiding our company in 2025.” David Denton, Chief Financial Officer and Executive Vice Presiden...
We identify and invest in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer’s pipeline and shape the future of our industry. Home About Partners Venture Investments Pfizer Ventures: How We Work We actively support our current...
In 2025, the emphasis will move to improving R&D productivity, while maintaining focus on margin expansion, commercial excellence, and shareholder-friendly capital allocation. Let me start with R&D. Across our pipeline, we believe we have a strong year of catalysts ahead of us and expect our new...
On this page, you’ll find information on the condition, its diagnosis and treatment, our pipeline, as well as useful Pfizer resources. Disease Education Information What is Meningococcal Disease? Meningococcal disease is an uncommon, but serious disease that can lead to death within 24 hours and...